Terns Pharmaceuticals (TERN) Operating Leases (2022 - 2023)
Terns Pharmaceuticals' Operating Leases history spans 2 years, with the latest figure at $63000.0 for Q3 2023.
- For Q3 2023, Operating Leases fell 91.03% year-over-year to $63000.0; the TTM value through Sep 2023 reached $63000.0, down 91.03%, while the annual FY2022 figure was $544000.0, N/A changed from the prior year.
- Operating Leases reached $63000.0 in Q3 2023 per TERN's latest filing, down from $223000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.0 million in Q1 2022 to a low of $63000.0 in Q3 2023.